Earnings

The stock of clinical-stage biopharmaceutical company Inhibrx Biosciences has experienced a dramatic ascent, appreciating by a remarkable 120 percent over...

A striking divergence has emerged in the Campbell Soup investment landscape. While institutional investors demonstrate growing confidence by accumulating shares,...

Red Cat Holdings unveiled what appeared to be blockbuster growth figures, yet its stock experienced a severe selloff. On November...

Meta Platforms delivered what should have been a celebratory earnings report, yet investors responded with a dramatic sell-off. The divergence...

Rocket Lab USA delivered what should have been a market-thrilling quarterly report, yet its shares defied expectations by trending downward....

Phathom Pharmaceuticals is demonstrating remarkable momentum in the market, fueled by unexpectedly robust quarterly earnings and significant clinical development milestones....

Rafael's stock is experiencing a severe downturn, driven by a combination of technical breakdowns, disappointing quarterly results, and intense selling...

In a surprising market reaction, Energous Corporation witnessed its stock decline following the announcement of what should have been celebratory...

Fuel Tech Inc. witnessed a dramatic after-hours selloff, with its stock price collapsing by 15.87% in response to its third-quarter...

Friday's trading session delivered a severe blow to Oxford Lane Capital shareholders as the stock plummeted to a fresh 52-week...